Key result
Anticancer therapies and cancer itself exert systemic effects that impact the right ventricle, highlighting the need for right heart assessment in cardio-oncology.
Highlights the critical need for right ventricular assessment in cardio-oncology, expanding beyond the traditional focus on left ventricular dysfunction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ramalingam et al. (2025) conducted a review in Cancer and cardiovascular toxicities. Anticancer therapies was evaluated. Anticancer therapies and cancer itself exert systemic effects that impact the right ventricle, highlighting the need for right heart assessment in cardio-oncology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: